| Dr Radika Roselyn Naidu, PHARMD | |
|
211 Quarry Rd Ste 108, Palo Alto, CA 94304-1416 | |
| (650) 326-2300 | |
| (650) 236-2351 |
| Full Name | Dr Radika Roselyn Naidu |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 211 Quarry Rd Ste 108, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609404003 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 79738 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Radika Roselyn Naidu, PHARMD 345 Barn Dance Way, Oakley, CA 94561-2116 Ph: (510) 673-4798 | Dr Radika Roselyn Naidu, PHARMD 211 Quarry Rd Ste 108, Palo Alto, CA 94304-1416 Ph: (650) 326-2300 |
News Archive
Plans by three Catholic hospital systems in Wisconsin to deny admitting privileges to doctors who perform abortions would "be in active violation of federal law," state Attorney General J. B. Van Hollen's Department of Justice said in a court filing last week. Federal law "provides that hospitals accepting federal funds may not discriminate against a physician because that physician has participated in or refused to participate in abortions," the state Justice Department said in its filing in federal court (Ahmed, 8/7).
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Long-term follow up with heart bypass patients treated in Veterans Affairs hospitals shows that 85 percent of left internal mammary artery grafts and 61 percent of vein grafts remain open (patent) after 10 years, and that these grafts are more likely to offer long-term success when they are attached to larger arteries on the heart, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.
New research identifies a previously unknown enzymatic mechanism that subverts the early host immune response and promotes pathogenicity by manipulating a common signaling pathway in host cells.
› Verified 6 days ago
Dr. Laura Elizabeth Stoddard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
See Lor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Jaimini Shah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Avenue, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Tam Bang Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4170 El Camino Real, Palo Alto, CA 94306 Phone: 650-858-2007 | |
Nidhu Baby Abraham, PHARM.D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Eric Fujii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd Ste 108, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Thuy Diem Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda, Palo Alto, CA 94034 Phone: 650-493-5000 |